A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 75 Years of Age With Thyroid Eye Disease

Conditions: Thyroid Eye Disease Interventions: Drug: TOUR006 - 20 MG; Other: Placebo; Drug: TOUR006 - 50 MG Sponsors: Tourmaline Bio, Inc. Recruiting

Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials